These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 24939736)

  • 1. The aging suppressor klotho: a potential regulator of growth hormone secretion.
    Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Longevity Hormone Klotho is a New Player in the Interacion of the Growth Hormone/Insulin-Like Growth Factor 1 Axis.
    Rubinek T; Wolf I; Modan-Moses D
    Pediatr Endocrinol Rev; 2016 Sep; 14(1):9-18. PubMed ID: 28508612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions.
    Rubinek T; Modan-Moses D
    Vitam Horm; 2016; 101():85-118. PubMed ID: 27125739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KL1 internal repeat mediates klotho tumor suppressor activities and inhibits bFGF and IGF-I signaling in pancreatic cancer.
    Abramovitz L; Rubinek T; Ligumsky H; Bose S; Barshack I; Avivi C; Kaufman B; Wolf I
    Clin Cancer Res; 2011 Jul; 17(13):4254-66. PubMed ID: 21571866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line.
    Fukuda T; Tanaka T; Hamaguchi Y; Kawanami T; Nomiyama T; Yanase T
    PLoS One; 2016; 11(10):e0164131. PubMed ID: 27706259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.
    Lekva T; Berg JP; Lyle R; Heck A; Ringstad G; Olstad OK; Michelsen AE; Casar-Borota O; Bollerslev J; Ueland T
    Endocrinology; 2013 Sep; 154(9):3331-43. PubMed ID: 23825128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT3 upregulation in pituitary somatotroph adenomas induces growth hormone hypersecretion.
    Zhou C; Jiao Y; Wang R; Ren SG; Wawrowsky K; Melmed S
    J Clin Invest; 2015 Apr; 125(4):1692-702. PubMed ID: 25774503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring for potential residual disease activity by serum insulin-like growth factor 1 and soluble Klotho in patients with acromegaly after pituitary surgery: is there an impact of the genomic deletion of exon 3 in the growth hormone receptor (d3-GHR) gene on "safe" GH cut-off values?
    Kohler S; Tschopp O; Sze L; Neidert M; Bernays RL; Spanaus KS; Wiesli P; Schmid C
    Gen Comp Endocrinol; 2013 Jul; 188():282-7. PubMed ID: 23648743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A transgenic model to determine the physiological role of liver-derived insulin-like growth factor I.
    Sjögren K; Jansson JO; Isaksson OG; Ohlsson C
    Minerva Endocrinol; 2002 Dec; 27(4):299-311. PubMed ID: 12511852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Complex World of Regulation of Pituitary Growth Hormone Secretion: The Role of Ghrelin, Klotho, and Nesfatins in It.
    Devesa J
    Front Endocrinol (Lausanne); 2021; 12():636403. PubMed ID: 33776931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormone hypersecretion.
    Vazquez-Martinez R; Martinez-Fuentes AJ; Pulido MR; Jimenez-Reina L; Quintero A; Leal-Cerro A; Soto A; Webb SM; Sucunza N; Bartumeus F; Benito-Lopez P; Galvez-Moreno MA; Castaño JP; Malagon MM
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2269-76. PubMed ID: 18349058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of human insulin-like growth factor-binding protein-1 increases circulating levels of growth hormone in mice.
    Cingel-Ristic V; Van Neck JW; Frystyk J; Drop SL; Flyvbjerg A
    Endocrinology; 2004 Sep; 145(9):4401-7. PubMed ID: 15166120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Klotho response to treatment with growth hormone and the role of IGF-I as a mediator.
    Rubinek T; Shahmoon S; Shabtay-Orbach A; Ben Ami M; Levy-Shraga Y; Mazor-Aronovitch K; Yeshayahu Y; Doolman R; Hemi R; Kanety H; Wolf I; Modan-Moses D
    Metabolism; 2016 Nov; 65(11):1597-1604. PubMed ID: 27733247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation.
    Lee Y; Kim JM; Lee EJ
    J Endocrinol; 2008 Nov; 199(2):191-9. PubMed ID: 18753332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone gene expression and secretion in aging rats is age dependent and not age-associated weight increase related.
    Velasco B; Cacicedo L; Escalada J; Lopez-Fernandez J; Sanchez-Franco F
    Endocrinology; 1998 Mar; 139(3):1314-20. PubMed ID: 9492067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signaling-2 deficiency induces molecular and metabolic changes that partially overlap with growth hormone-dependent effects.
    Rico-Bautista E; Greenhalgh CJ; Tollet-Egnell P; Hilton DJ; Alexander WS; Norstedt G; Flores-Morales A
    Mol Endocrinol; 2005 Mar; 19(3):781-93. PubMed ID: 15563548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I regulates growth hormone secretion and messenger ribonucleic acid levels in human pituitary tumor cells.
    Yamashita S; Weiss M; Melmed S
    J Clin Endocrinol Metab; 1986 Sep; 63(3):730-5. PubMed ID: 3016022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.